Long-term OL Study of [S,S]-RBX in Patients With Fibromyalgia

Stopped early · Phase 3

Conditions studied: Fibromyalgia

In brief

To evaluate the lon-term safety and tolerability of \[S,S\]-reboxetine in patients with fibromyalgia

Key facts

Study ID

NCT00607256

Run by

Pfizer

People needed

500

Starts

2007-10-20

Expected to finish

2009-05-18

Last updated by the study team

2019-12-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of patients meeting the ACR criteria for fibromyalgia (i.e. widespread pain present for at least 3 months, and pain in at least 11 of 18 specific tender point sites)

You may not qualify if…

• Patients with other severe pain (e.g. DPN and PHN) that may confound assessment or self-evaluation of the pain associated with fibromyalgia

Where it is running

• Pfizer Investigational Site — Santa Ana, California, United States
• Pfizer Investigational Site — Denver, Colorado, United States
• Pfizer Investigational Site — Jacksonville, Florida, United States
• Pfizer Investigational Site — Ocala, Florida, United States
• Pfizer Investigational Site — Ocala, Florida, United States
• Pfizer Investigational Site — West Palm Beach, Florida, United States
• Pfizer Investigational Site — Moline, Illinois, United States
• Pfizer Investigational Site — Prairie Village, Kansas, United States
• Pfizer Investigational Site — Lexington, Kentucky, United States
• Pfizer Investigational Site — Jefferson City, Missouri, United States
• Pfizer Investigational Site — St Louis, Missouri, United States
• Pfizer Investigational Site — Kenilworth, New Jersey, United States
• Pfizer Investigational Site — Rochester, New York, United States
• Pfizer Investigational Site — Staten Island, New York, United States
• Pfizer Investigational Site — Cary, North Carolina, United States
• Pfizer Investigational Site — Minot, North Dakota, United States
• Pfizer Investigational Site — Cincinnati, Ohio, United States
• Pfizer Investigational Site — Marion, Ohio, United States
• Pfizer Investigational Site — Medford, Oregon, United States
• Pfizer Investigational Site — Bethlehem, Pennsylvania, United States
• Pfizer Investigational Site — Duncansville, Pennsylvania, United States
• Pfizer Investigational Site — Cranston, Rhode Island, United States
• Pfizer Investigational Site — Cumberland, Rhode Island, United States
• Pfizer Investigational Site — Lincoln, Rhode Island, United States
• Pfizer Investigational Site — Orangevale, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.